Curaleaf Holdings (CURLF) EBT (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly EBT of -$28.6 million for Q1 2026, down 74.57% year-on-year from -$112.6 million in Q1 2025, and down 70.97% on a QoQ basis from -$16.7 million in Q4 2025.
Curaleaf Holdings (CURLF) EBT (2019 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported EBT for 8 consecutive years, with -$28.6 million the latest figure, recorded in Q1 2026.
- Quarterly EBT fell 74.57% year-over-year to -$28.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$88.9 million (up 24.85% YoY) and the FY2025 annual result came in at -$78.2 million, up 31.0% from the prior year.
- EBT declined to -$28.6 million in Q1 2026 per CURLF's latest filing, from -$16.7 million in the prior quarter.
- Over the last five years, EBT for CURLF reached as high as $31.9 million in Q2 2022 and fell as low as -$60.6 billion in Q4 2023.
- A 5-year average of -$3.6 billion and a median of -$17.2 million in 2024 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT soared 223.7% — and 2023, when it sank 24226.2%.
- Year by year, EBT stood at -$249.2 million in 2022, then plunged by 24226.2% to -$60.6 billion in 2023, then surged by 99.88% to -$73.0 million in 2024, then jumped by 77.05% to -$16.7 million in 2025, then sank by 70.97% to -$28.6 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$28.6 million, -$16.7 million, and -$24.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | -28.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.63 Mn |
| Dec 31, 2025 | -16.75 Mn |
| Sep 30, 2025 | -24.31 Mn |
| Jun 30, 2025 | -19.22 Mn |
| Mar 31, 2025 | -16.40 Mn |
| Dec 31, 2024 | -72.96 Mn |
| Sep 30, 2024 | -11.78 Mn |
| Jun 30, 2024 | -17.16 Mn |
| Mar 31, 2024 | -11.49 Mn |
| Dec 31, 2023 | -60.63 Bn |
| Sep 30, 2023 | -35.95 Mn |
| Jun 30, 2023 | -24.64 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -249.22 Mn |
| Sep 30, 2022 | 8.55 Mn |
| Jun 30, 2022 | 31.90 Mn |
| Mar 31, 2022 | 21.39 Mn |
| Dec 31, 2021 | -40.37 Mn |
| Sep 30, 2021 | 2.64 Mn |
| Jun 30, 2021 | 34.34 Mn |